Likewise, JMJD1C, a histone demethylase associated with epigenetic regulation, harboured pathogenetic or unknown variants in 11% of our breast NETs and only 2% in IDCs. The gene discussed is JMJD1C; the disease is breast neuroendocrine neoplasm.